Skip to NavigationSkip to content

Pharmafile - Business Services News

Y-mAbs Therapeutics has announced that the FDA has approved Danyelza in combination with granulocyte-macrophage colony-stimulating factor (“GM-CSF...
Coronavirus infection rates across England are levelling off after a slight decrease in cases last week, according to the Office of National...
The proposed plan to import cheaper Canadian drugs to Florida is being challenged by the US pharmaceutical lobby in court. 
The FDA has approved the first drug to treat the rare genetic disorder progeria, a rare condition which causes cells to age rapidly and prematurely,...
Besides the latest vaccine and industry news, the new issue also includes features on the diabetes space and how it has been affected by the COVID-19...
Over the course of his 30-year career in biopharmaceuticals, Barker has held a number of executive leadership roles at companies including Huntsworth...
The first clinical trial to focus on multiple sclerosis (MS) patients who can’t walk will begin enrolling patients next year.
Five different coronavirus vaccines from China are being tested in Phase 3 trials around the world.
A new global healthcare partnership funded by the World Economic Forum (WEF), the London School of Economics and AstraZeneca has selected Vietnam as...
AstraZeneca’s Calquence has failed to improve survival rates and prevent lung failure in patients hospitalised with COVID-19.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches